267 related articles for article (PubMed ID: 27805524)
41. Five years renal transplantation data: Single-center experience from Iraq.
Ali AA; Al-Saedi AJ; Al-Mudhaffer AJ; Al-Taee KH
Saudi J Kidney Dis Transpl; 2016 Mar; 27(2):341-7. PubMed ID: 26997389
[TBL] [Abstract][Full Text] [Related]
42. Where to Draw the Line in Surgical Obesity for Renal Transplant Recipients: An Outcome Analysis Based on Body Mass Index.
Mehta A; Ghazanfar A; Marriott A; Morsy M
Exp Clin Transplant; 2019 Feb; 17(1):37-41. PubMed ID: 29619909
[TBL] [Abstract][Full Text] [Related]
43. Anticancer effect of sirolimus in renal allograft recipients with de novo malignancies.
Boratyńska M; Watorek E; Smolska D; Patrzałek D; Klinger M
Transplant Proc; 2007 Nov; 39(9):2736-9. PubMed ID: 18021973
[TBL] [Abstract][Full Text] [Related]
44. Human leukocyte antigen-DR mismatched pediatric renal transplant: patient and graft outcome with different kidney donor sources.
Al-Otaibi T; Gheith O; Mosaad A; Nampoory MR; Halim M; Said T; Nair P
Exp Clin Transplant; 2015 Apr; 13 Suppl 1():117-23. PubMed ID: 25894139
[TBL] [Abstract][Full Text] [Related]
45. Repeat Kidney Transplantation After Failed First Transplant in Childhood: Past Performance Informs Future Performance.
Gupta M; Wood A; Mitra N; Furth SL; Abt PL; Levine MH
Transplantation; 2015 Aug; 99(8):1700-8. PubMed ID: 25803500
[TBL] [Abstract][Full Text] [Related]
46. Outcomes of renal transplantation after end-stage renal disease due to diabetic nephropathy: a single-center experience.
Tokodai K; Amada N; Kikuchi H; Haga I; Takayama T; Nakamura A
Transplant Proc; 2012 Jan; 44(1):77-9. PubMed ID: 22310584
[TBL] [Abstract][Full Text] [Related]
47. De Novo Malignancies After Liver Transplantation: A Single Institution Experience.
Egeli T; Unek T; Ozbilgin M; Agalar C; Derici S; Akarsu M; Unek IT; Aysin M; Bacakoglu A; Astarcıoglu I
Exp Clin Transplant; 2019 Feb; 17(1):74-78. PubMed ID: 29237362
[TBL] [Abstract][Full Text] [Related]
48. Clinical and Economic Consequences of Early Cancer After Kidney Transplantation in Contemporary Practice.
Dharnidharka VR; Naik AS; Axelrod D; Schnitzler MA; Xiao H; Brennan DC; Segev DL; Randall H; Chen J; Kasiske B; Lentine KL
Transplantation; 2017 Apr; 101(4):858-866. PubMed ID: 27490413
[TBL] [Abstract][Full Text] [Related]
49. De Novo Malignancy After Heart, Kidney, and Liver Transplant: A Nationwide Study in Taiwan.
Yeh CC; Khan A; Muo CH; Yang HR; Li PC; Chang CH; Chen TL; Jeng LB; Liao CC
Exp Clin Transplant; 2020 Apr; 18(2):224-233. PubMed ID: 32133940
[TBL] [Abstract][Full Text] [Related]
50. [Infectious and neoplasic complications after kidney transplantation].
Mourad G; Serre JE; Alméras C; Basel O; Garrigue V; Pernin V; Le Quintrec M
Nephrol Ther; 2016 Nov; 12(6):468-487. PubMed ID: 27686031
[TBL] [Abstract][Full Text] [Related]
51. [REIN Report 2011--summary].
Couchoud C; Lassalle M; Jacquelinet C
Nephrol Ther; 2013 Sep; 9 Suppl 1():S3-6. PubMed ID: 24119584
[TBL] [Abstract][Full Text] [Related]
52. Clinicoepidemiologic study of posttransplant diabetes after living-donor renal transplant.
Elmagd MM; Bakr MA; Metwally AH; Wahab AM
Exp Clin Transplant; 2008 Mar; 6(1):42-7. PubMed ID: 18405244
[TBL] [Abstract][Full Text] [Related]
53. Malignancy after heart transplantation: analysis of 24-year experience at a single center.
Yagdi T; Sharples L; Tsui S; Large S; Parameshwar J
J Card Surg; 2009; 24(5):572-9. PubMed ID: 19486222
[TBL] [Abstract][Full Text] [Related]
54. The Long-Term Effect of Hepatitis C Virus on the Outcome of Live-Donor Kidney Transplant Recipients. A Retrospective Study.
Denewar AA; Monem El-Hendy YA; Wafa EW; Ghorab AA; Sheashaa HA; Rashad RH; Nagib AM; Neamatallah AH; Abbas MH; Shokeir AA
Exp Clin Transplant; 2015 Oct; 13(5):402-7. PubMed ID: 26450463
[TBL] [Abstract][Full Text] [Related]
55. Malignancy in renal transplant recipients: a single-center experience in Thailand.
Ruangkanchanasetr P; Lauhawatana B; Leawseng S; Kitpanich S; Lumpaopong A; Thirakhupt P
J Med Assoc Thai; 2012 May; 95 Suppl 5():S12-6. PubMed ID: 22934439
[TBL] [Abstract][Full Text] [Related]
56. De novo thrombotic microangiopathy after kidney transplantation: clinical features, treatment, and long-term patient and graft survival.
Caires RA; Marques ID; Repizo LP; Sato VA; Carmo LP; Machado DJ; de Paula FJ; Nahas WC; David-Neto E
Transplant Proc; 2012 Oct; 44(8):2388-90. PubMed ID: 23026601
[TBL] [Abstract][Full Text] [Related]
57. Risk factors of long-term graft loss in renal transplant recipients with chronic allograft dysfunction.
Khalkhali HR; Ghafari A; Hajizadeh E; Kazemnejad A
Exp Clin Transplant; 2010 Dec; 8(4):277-82. PubMed ID: 21143092
[TBL] [Abstract][Full Text] [Related]
58. Autosomal-dominant polycystic kidney disease as a risk factor for diabetes mellitus following renal transplantation.
de Mattos AM; Olyaei AJ; Prather JC; Golconda MS; Barry JM; Norman DJ
Kidney Int; 2005 Feb; 67(2):714-20. PubMed ID: 15673321
[TBL] [Abstract][Full Text] [Related]
59. Skin cancer after renal transplantation: Results of a multicenter study in Iran.
Einollahi B; Nemati E; Lessan-Pezeshki M; Simforoosh N; Nourbala MH; Rostami Z; Nafar M; Pourfarziani V; Beiraghdar F; Mahdavi-Mazdeh M; Ahmadpour P; Makhdoomi K; Ghafari A; Ardalan MR; Taebi Khosroshahi H; Oliaei F; Shahidi S; Makhlogh A; Azmandian J; Samimagham HR; Shabazian H
Ann Transplant; 2010; 15(3):44-50. PubMed ID: 20877266
[TBL] [Abstract][Full Text] [Related]
60. Diabetes Mellitus After Pediatric Kidney Transplant.
Almardini R; Salaita G; Albderat J; Alrabadi K; Alhadidi A; Alfarah M; Abu Ruqa'a A; Dahabreh D
Exp Clin Transplant; 2019 Apr; 17(2):165-169. PubMed ID: 29863453
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
